Myeloid Derived Suppressor Cells and Chronic Myeloid Leukemia

NCT03214718 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia Patients

Interventions

DIAGNOSTIC_TEST: Measurement level of myeloid derived suppressor cells in CML patients treated with imatinibe 400 mg/day
DIAGNOSTIC_TEST: Measurement level of myeloid derived suppressor cells in CML patients treated with nilotinib 600 mg/day

Sponsor

Assiut University